FibroBiologics, Inc. Common Stock

$0.61
(as of Jul 8, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for FibroBiologics, Inc. Common Stock

Stock Price
$0.61
Ticker Symbol
FBLG
Exchange
NASDAQ

Industry Information for FibroBiologics, Inc. Common Stock

Sector
Healthcare
Industry
Biotechnology

Company Description for FibroBiologics, Inc. Common Stock

Country
USA
Full Time Employees
13

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

Fundamentals for FibroBiologics, Inc. Common Stock

Market Capitalization
$24,015,736
EBITDA
$-14,643,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
0
Earnings per Share
$-0.21
Earnings per Share Estimate Next Year
Profit Margin
Shares Outstanding
39,241,400
Percent Owned by Insiders
21.42%
Percent Owned by Institutions
16.86%
52-Week High
52-Week Low

Technical Indicators for FibroBiologics, Inc. Common Stock

50-Day Moving Average
200-Day Moving Average
RSI
31.61
0.07

Analyst Ratings for FibroBiologics, Inc. Common Stock

Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0

News About FibroBiologics, Inc. Common Stock

Jul 7, 2025, 4:35 PM EST
HOUSTON, July 07, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. See more.
Jun 16, 2025, 4:48 PM EST
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. See more.
Jun 16, 2025, 4:35 PM EST
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. See more.
Jun 16, 2025, 9:50 AM EST
HOUSTON, June 16, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. See more.